Differentiating Antiphospholipid syndrome from other diseases

Revision as of 19:30, 26 April 2018 by Feham Tariq (talk | contribs)
Jump to navigation Jump to search

Antiphospholipid syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Antiphospholipid syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Differentiating Antiphospholipid syndrome from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating Antiphospholipid syndrome from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating Antiphospholipid syndrome from other diseases

CDC on Differentiating Antiphospholipid syndrome from other diseases

Differentiating Antiphospholipid syndrome from other diseases in the news

Blogs on Differentiating Antiphospholipid syndrome from other diseases

Directions to Hospitals Treating Antiphospholipid syndrome

Risk calculators and risk factors for Differentiating Antiphospholipid syndrome from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

Antiphospholipid syndrome should be differentiated from conditions such as hemolytic uremic syndrome-thrombotic thrombocytopenic purpura (HUS-TTP), disseminated intravascular coagulation (DIC), and vasculitis .

Differentiating Antiphospholipid antibody syndrome from other Diseases


Abbreviations: ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptide, ASO= Antistreptolysin O antibody, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure, PCR= Polymerase chain reaction, PFT= Pulmonary function test.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Dyspnea Fever Weight loss Arthralgia Skin manifestation Organomegaly Focal neurological disorder CBC ESR Antibodies Other CT scan Other
Antiphospholipid syndrome + + - - Livedo reticularis, palpable purpura, leg ulcers, raynaud phenomena hepatomegaly,

splenomegaly

Stroke, transient ischemic attack Schistocytes on peripheral smear,Thrombocytopenia, Hemolytic anemia Lupus anticoagulant,anticardiolipin antibodies - Stroke,

Pulmonary embolism, Budd-Chiari syndrome

- Noninflammatory bland thrombosis without perivascular inflammation Hx of thrombosis and antiphospholipid antibodies Miscarriage, Pulmonary hypertension
Systemic lupus erythematosus (SLE)
Thrombosis Thrombophilia DIC
HUS + + - + Liver/spleen swelling + Anemia,

Thrombocytopenia, Reticulocytosis

ADAMTS13 Increased lactate dehydrogenase Thalamibrainstem, or cerebellumabnormality Microthrombosesinclude fibrin thrombi that may occlude the glomerular tufts Clinical findings coupled with laboratory abnormalities HematuriaProteinuria 
ITP
HELLP
Paroxysmal nocturnal hemoglobinuria (PNH)
Heparin-induced thrombocytopenia (HIT)
Myeloproliferative diseases
Recurrent pregnancy loss Uterine abnormality
Chromosomal abnormality
Hypothyroidism

References

Template:WH Template:WS